Catalina Barceló

Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals

Manel Aouri, Catalina Barceló, Monia Guidi et al. · Antimicrobial Agents and Chemotherapy · 2016 · 53 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183

Laura E. de Vries, Patrick A.M. Jansen, Catalina Barceló et al. · Nature Communications · 2022 · 41 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Population pharmacokinetics of dolutegravir: influence of drug–drug interactions in a real-life setting

Catalina Barceló, Manel Aouri, Perrine Courlet et al. · Journal of Antimicrobial Chemotherapy · 2019 · 38 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid

Manel Aouri, Catalina Barceló, Béatrice Ternon et al. · Drug Metabolism and Disposition · 2015 · 32 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17

Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study.

Bridget E. Barber, Melissa Fernandez, Hardik B. Patel et al. · LSTM Online Archive (Liverpool School of Tropical Medicine) · 2022 · 30 citations

Medicine, Pharmacokinetics, Pharmacology +16